I'll stop posting the into paragraph after this thread.....
I thought we might pool our knowledge and build a very high quality port together. Sector by sector. I'll ask that you not copy your entire port into this thread. You can post again later. Healthcare is diverse to include pharma, equipment, insurance, biotech, etc. Maybe follow a few basic rules....
1. Pick one or two stocks and tell us why they would be your pick if you could only choose a few stocks from each sector.
2. Assume a five year hold minimum, because if it's truly good for five it's probably good for 25. Five years is enough time to sort out current challenges.
3. Ignore current valuation for the most part. Entry matters of course, but great ports aren't built overnight anyway.
4. Suggest a stock you have some conviction to own soon. Suggest a stock you would avoid.
Bristol-Myers Squibb, BMY This one may take some patience with the Celgene merger in progress. It's a strong buy IMO. One of the few healthcare stocks with a very reasonable PE. The dividend is well above 3%. Revenue growth projected above 10%. They have some debt to contend with.
Stocks to avoid? This is a tougher one. Most have litigation risk at some point. I tend to avoid pure biotech plays. It's challenging to find one that can go five years without hitting a very rough patch.
I thought we might pool our knowledge and build a very high quality port together. Sector by sector. I'll ask that you not copy your entire port into this thread. You can post again later. Healthcare is diverse to include pharma, equipment, insurance, biotech, etc. Maybe follow a few basic rules....
1. Pick one or two stocks and tell us why they would be your pick if you could only choose a few stocks from each sector.
2. Assume a five year hold minimum, because if it's truly good for five it's probably good for 25. Five years is enough time to sort out current challenges.
3. Ignore current valuation for the most part. Entry matters of course, but great ports aren't built overnight anyway.
4. Suggest a stock you have some conviction to own soon. Suggest a stock you would avoid.
Bristol-Myers Squibb, BMY This one may take some patience with the Celgene merger in progress. It's a strong buy IMO. One of the few healthcare stocks with a very reasonable PE. The dividend is well above 3%. Revenue growth projected above 10%. They have some debt to contend with.
Stocks to avoid? This is a tougher one. Most have litigation risk at some point. I tend to avoid pure biotech plays. It's challenging to find one that can go five years without hitting a very rough patch.